Mylan Inc. to Speak at the Bank of America Merrill Lynch Global Healthcare Conference

PITTSBURGH, Sept. 5, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that Chief Financial Officer John Sheehan will speak at the Bank of America Merrill Lynch Global Healthcare Conference on Thursday Sept. 12, 2013 at 1 p.m. BST, 8 a.m. EDT, at the Bank of America Merrill Lynch Financial Centre, London, UK. The conference will be webcast live and can be accessed on Mylan's Investor Relations Web site at http://investor.mylan.com/.

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same location for a limited time.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com

SOURCE Mylan Inc.